Liquidmetal Technologies Inc (LQMT)

[darknight23]

SALT LAKE CITY, Sept. 5, 2019 /PRNewswire/ -- CoNextions Medical, a developer of novel soft tissue repair devices, announced today that it has completed enrollment in a key clinical trial for its pioneering tendon-to-tendon repair device, CoNextions TR. Pending successful results of the trial, the company plans to submit a 510(k) application to the FDA for US marketing approval in the first quarter of 2020.

https://www.prnewswire.com/news-releases/conextions-medical-completes-enrollment-in-key-clinical-trial-of-novel-device-for-tendon-to-tendon-repair-300912692.html

Backed by an experienced team and a premier medical advisory board, CoNextions Medical looks to innovate soft tissue tendon repair. In an effort to find a manufacturing solution that allows for improved performance without inflated cost, Liquidmetal technology came to light.

https://www.liquidmetal.com/conextions/

This revenue will definitely be attributable to LQMT.